@Article{096504016X14803482769179,
AUTHOR = {Jiateng Zhong, Haijun Wang, Jian Yu, Jinghang Zhang, Hui Wang},
TITLE = {Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation  and Invasion of Breast Cancer Cells},
JOURNAL = {Oncology Research},
VOLUME = {25},
YEAR = {2017},
NUMBER = {6},
PAGES = {959--965},
URL = {http://www.techscience.com/or/v25n6/56878},
ISSN = {1555-3906},
ABSTRACT = {Forkhead box L1 (FOXL1) is a member of the Forkhead box (FOX) superfamily and was reported to be dysregulated in various types of cancers. However, its expression pattern and underlying cellular function in breast 
cancer remain largely unexplored. Thus, the aim of this study was to detect FOXL1 expression in breast cancer 
and to analyze its role in the progression of breast cancer. Our results demonstrated that FOXL1 expression at 
both the mRNA and protein levels was downregulated in breast cancer tissues and cell lines. Ectopic FOXL1 
suppressed breast cancer cell proliferation, migration, and invasion in vitro. Furthermore, overexpression of 
FOXL1 significantly attenuated tumor growth in breast xenograft models in vivo. Finally, overexpression of 
FOXL1 significantly downregulated the protein expression levels of β-catenin, c-Myc, and cyclin D1 in MDAMB-231 cells. Taken together, the present study demonstrated that FOXL1 inhibited the proliferation, invasion, 
and migration of breast cancer in vitro and breast tumor growth in vivo through deactivating the Wnt/β-catenin 
signaling pathway. Thus, these findings suggest that FOXL1 may be a potential novel target for breast cancer 
therapy.},
DOI = {10.3727/096504016X14803482769179}
}